Literature DB >> 9693926

Neuro-laryngeal involvement in Churg-Strauss syndrome.

M Mazzantini1, B Fattori, F Matteucci, P Gaeta, F Ursino.   

Abstract

We report our clinical experience in managing a 59-year-old Italian male with Churg-Strauss syndrome (CSS) whose first clinical manifestation was a persistent dysphonia; the patient worked as a mechanic. Video-laryngostroboscopic examination revealed paresis of the right vocal fold with a reduction in adduction together with incomplete glottal closure. Spectrographic and spirometric tests both showed abnormal changes. Laryngeal electromyography revealed neurogenic damage of the right thyroarytenoid and crycoarytenoid muscles. Due to the appearance of typical signs of systemic involvement of CSS as a necrotizing vasculitis, the patient was admitted to the Rheumatology Unit of the University of Pisa. Histologic analysis of a skin lesion on the patient's foot confirmed the diagnosis. Treatment with 6-methylprednisolone quickly brought remission from systemic and laryngeal symptoms, as well as improvement in the results of video-laryngostroboscopic, spectrographic and laryngeal myographic tests.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693926     DOI: 10.1007/s004050050064

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  3 in total

1.  Churg-Strauss Syndrome as an Unusual Cause of Dysphagia: Case Report.

Authors:  Jihye Park; Sun Im; Su-Jin Moon; Geun-Young Park; Yongjun Jang; Yeonjin Kim
Journal:  Ann Rehabil Med       Date:  2015-06-30

2.  Severe microscopic polyangiitis with unilateral vocal cord paralysis as initial manifestation.

Authors:  Luis Felipe Flores-Suárez; Marco Antonio Alba; Gabriel Tona
Journal:  Colomb Med (Cali)       Date:  2017-03-30

3.  A laryngeal presentation of Churg-Strauss syndrome in childhood.

Authors:  Ahmed Y Al-Ammar; Subhan S Yasin; Saleh Zaid Al-Muhsen; Muslim M Al-Saadi; Mohammad O Al-Sohaibani
Journal:  Ann Saudi Med       Date:  2009 Mar-Apr       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.